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Neural stem cells in the subventricular zone (SVZ) of the lateral ventricle of adult rodent
brain generate oligodendrocyte progenitor cells (OPCs) that disperse throughout the corpus
callosum and striatum where some of OPCs differentiate into mature oligodendrocytes.
Studies in animal models of stroke demonstrate that cerebral ischemia induces oligoden-
drogenesis during brain repair processes.This article will review evidence of stroke-induced
proliferation and differentiation of OPCs that are either resident in white matter or are
derived from SVZ neural progenitor cells and of therapies that amplify endogenous
oligodendrogenesis in ischemic brain.
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INTRODUCTION
More than 80% of stroke is ischemic stroke triggered by blockage
of blood ﬂow within major cerebral arteries by clots, which leads
to infarction in white and gray matter (Dewar et al., 2003; Cui
et al., 2009; Karki et al., 2009). Studies from experimental stroke
and patients with stroke show that adult brain has the capability to
self-repair in response to stroke. However, the spontaneous brain
repair process is constrained with limited improvement of neuro-
logical outcome (Benowitz and Carmichael, 2010). Thus, stroke
remains the leading cause of adult disability around the world
(Demaerschalk et al., 2010).
Neurogenesis, oligodendrogenesis, angiogenesis, and astroglio-
sis are major brain repair processes during stroke recovery (Zhang
and Chopp, 2009). Cerebral ischemia induces neurogenesis and
angiogenesis in the adult human and rodent brains, which have
been studied in depth (Jin et al., 2001, 2006; Zhang et al., 2001;
Arvidsson et al., 2002; Parent et al., 2002;Macas et al., 2006;Minger
et al., 2007; Curtis et al., 2011). In contrast, stroke-induced oligo-
dendrogenesis in ischemic brain has not been broadly studied
(Dewar et al., 2003; Pham et al., 2012). Oligodendrocytes, myelin
forming cells in the central nervous system (CNS), are vulnera-
ble to cerebral ischemia (Pantoni et al., 1996; Dewar et al., 2003).
Loss of oligodendrocytes and their myelin impairs axonal func-
tion (Franklin, 2002). New oligodendrocytes are required to form
myelin sheaths for sprouting axons during brain repair processes
after stroke because mature oligodendrocytes do not proliferate in
the adult brain and injured oligodendrocytes no longer form new
myelin sheets (Gensert and Goldman, 1997; Gregersen et al., 2001;
Franklin, 2002; Menn et al., 2006; Franklin and Ffrench-Constant,
2008; McTigue and Tripathi, 2008). New oligodendrocytes are
derived from non-myelinating oligodendrocyte progenitor cells
(OPCs; Gensert and Goldman, 1997; Franklin, 2002). Using an
inducible cre-lox fate mapping strategy in adult neural progeni-
tor cells of transgenic mice, recent studies demonstrate that OPCs
originating fromneural progenitor cells in the subventricular zone
(SVZ) of the lateral ventricle differentiate into myelin forming
oligodendrocytes under physiological and ischemic conditions
(Li et al., 2010; Zawadzka et al., 2010; Zhang et al., 2011, 2012;
Rafalski et al., 2013). Preclinical studies show that enhance-
ment of endogenous oligodendrogenesis in ischemic brain by
cell-based and pharmacological therapies facilitates brain repair
processes and reduces neurological deﬁcits (Li et al., 2005; Zhang
and Chopp, 2009; Morris et al., 2010; Zhang et al., 2010b,
2012). These ﬁndings have led to a hope for a neurorestora-
tive treatment of stroke which aims to manipulate endogenous
neurogenesis, angiogenesis and oligodendrogenesis and thereby
to enhance brain repair. In this article, we will review pro-
liferation and differentiation of OPCs in adult rodent brain
after focal cerebral ischemia and therapies that amplify endoge-
nous oligodendrogenesis in ischemic brain. Molecular mecha-
nisms that mediate oligodendrogenesis after stroke will also be
reviewed.
STROKE INDUCES OLIGODENDROGENESIS
Oligodendrocyte progenitor cells identiﬁedby the chondroitin sul-
fate proteoglycanNG2 and platelet-derived growth factor receptor
α (PDGFRα) comprise 3–9% of the total cell number in the adult
CNS and are the majority of proliferating cells (Dawson et al.,
2003; McTigue and Tripathi, 2008). These OPCs continuously dif-
ferentiate into mature myelinating oligodendrocytes throughout
the gray and white matter of the adult brain (Gensert and Gold-
man, 1997; Franklin, 2002; McTigue and Tripathi, 2008; Fancy
et al., 2011). OPCs are locally present in the corpus callosum,
the striatum, and the cortex and are derived from neural pro-
genitor cells in the SVZ (Nait-Oumesmar et al., 1999; Roy et al.,
1999; Picard-Riera et al., 2002; Fancy et al., 2004; Menn et al.,
2006). The SVZ contains glial ﬁbrillary acidic protein (GFAP)
expressing neural stem cells that generate intermediate progenitors
(Alvarez-Buylla et al., 2008). Retroviral lineage tracking studies
show that although the majority of the neural progenitor cells
give rise to homogeneous neuronal progeny, some progenitor
cells generate OPCs in the adult brain (Menn et al., 2006). OPCs
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generated from the SVZ migrate to white matter tracts of corpus
callosum, ﬁmbria fornix and striatum (Menn et al., 2006). Studies
of inducible Cre recombination transgenic mice conﬁrm Ascl1-
and nestin-expressing neural stem and progenitor cells in adult
brain generate OPCs (Li et al., 2010; Zhang et al., 2011, 2012).
Early retroviral lineage tracking studies show that the production
of OPCs by adult SVZ neural stem cells is limited (Menn et al.,
2006). However, using nestin CreER; mT/mG mice in which Cre
recombination leads to deletion of a membrane-targeted tomato
ﬂuorescent protein and expression of a membrane-targeted green
ﬂuorescent protein in adult neural stem and progenitor cells,
Rafaski et al. (2013) recently demonstrated that a substantial frac-
tion of OPCs are generated from adult SVZ nestin-expressing
neural stem and progenitor cells under physiological condition.
In vitro, tracking the lineage progression of primary adult SVZ
neural stem cells, Ortega et al. (2013) recently demonstrated that
the adult neural stem cells generated oligodendrogliogenic clones
which gave raise to NG2 positive OPCs by symmetric cell division
or NG2 positive OPC and GFAP positive astroglial progeny by
asymmetric cells division. However, oligodendrogliogenic clones
do not generate OPC and neuronal progeny. These data suggest
that adult neural progenitor cells contain oligodendrogliogenic
and neuronal lineages and they are distinct and not shared
(Ortega et al., 2013).
Stroke acutely induces mature oligodendrocyte damage, lead-
ing to loss ofmyelin,which is associatedwith loss of axons (Pantoni
et al., 1996; Dewar et al., 2003). However, during stroke recovery
there is a signiﬁcant increase in generation of OPCs and some
of them become mature myelinating oligodendrocytes in peri-
infarct gray and white matter where sprouting axons are present
(Gregersen et al., 2001; Zhang et al., 2011, 2012; Ueno et al., 2012).
An increase inmaturemyelinatingoligodendrocytes observed after
stroke in the adult brain likely result from new oligodendrocytes
differentiated from OPCs. Studies in adult transgenic mice that
express a tamoxifen-inducible form of Cre recombinase under
control of an Ascl1 or nestin promoter have shown that OPCs
located in the gray and white matter and OPCs from the SVZ
are involved in generation of new oligodendrocytes (Zhang et al.,
2011, 2012). During the ﬁrst 2 weeks after stroke, a robust increase
in Ascl1-expressing OPCs was observed in ischemic boundary
regions of the gray and white matter. However, 2 months after
stroke, the Ascl1 or nestin lineage cells in per-infarct white mat-
ter exhibited myelin sheet morphology and expressed protein
components of myelin, cyclic nucleotide 3’-phosphodiesterase
(CNPase) and myelin basic protein (MBP; Zhang et al., 2011,
2012). In addition to resident OPCs in white matter, stroke
recruits SVZ neural progenitor cell-generated OPCs by attracting
them from the SVZ to the ischemic striatum and corpus callo-
sum (Zhang et al., 2010b, 2011, 2012). It is uncertain whether
SVZ neural progenitor cells share neuronal and oligodendrocyte
lineages after experimental induction of demyelination, although
under physiological conditions they do not (Ortega et al., 2013).
Demyelination in the corpus callosum produced by lysolecithin
induces SVZ generated doublecortin (DCX) lineage neuroblasts
to differentiate into OPCs (Jablonska et al., 2010). However, DCX
lineage OPCs were not detected in adult ischemic brain, although
stroke greatly increases DCX lineage neuroblasts (Liu et al., 2009;
Zhang et al., 2009). These data indicate that stroke induces oligo-
dendrogenesis by recruiting resident OPCs in white and gray
matter and OPCs generated by SVZ neural progenitor cells and
that new oligodendrocytes generated after stroke become mature
myelinating oligodendrocytes. SVZ generated OPCs are present
in humans after demyelination (Nait-Oumesmar et al., 2007).
Stromal-derived factor 1α (SDF-1α) and vascular endothelial
growth factor (VEGF) secreted by activated cerebral endothelial
cells in the ischemic boundary region are likely involved in OPC
migration to peri-infarct gray and white matters (Zhang et al.,
2000; Imitola et al., 2004; Ohab et al., 2006; Robin et al., 2006;
Hayakawa et al., 2012; Bain et al., 2013; de Castro et al., 2013).
Glutamatergic inputs from damaged axons in the corpus callosum
may also trigger migration of OPCs from the SVZ to peri-infarct
areas (Etxeberria et al., 2010).
In addition to serving as a source to generate myelination
oligodendrocytes, OPCs act as a surveillance network to detect
brain injury (Hughes et al., 2013). Molecules produced by reactive
astrocytes and microglia after brain injury trigger OPC prolif-
eration and regulate OPC differentiation (Moore et al., 2011;
Miron et al., 2013). For example, insulin-like growth factor-1
(IGF-1) and bone morphogenic proteins (BMPs) secreted by
astrocytes promotes and inhibit, respectively, the generation
of myelinating oligodendrocytes (Moore et al., 2011). Transfor-
mation of pro-inﬂammatory (M1) microglia and macrophages
to anti-inﬂammatory (M2) drives OPCs to differentiate into
mature oligodendrocytes in a model of focal demyelination
(Miron et al., 2013). However, the role of such cross-talk
in mediating stroke-induced oligodendrogenesis has not been
investigated.
THERAPIES ENHANCE ENDOGENOUS
OLIGODENDROGENESIS IN THE ISCHEMIC BRAIN
Stroke increases OPC generation in the SVZ, yet endogenous
oligodendrogenesis from SVZ neural stem and progenitor cells
in response to stroke is limited. Emerging preclinical studies show
that cell and pharmacological based therapies initiated at days
after stroke enhance endogenous oligodendrogenesis and axonal
outgrowth (Li et al., 2005; Zhang and Chopp, 2009; Morris et al.,
2010; Zhang et al., 2010b, 2012). Erythropoietin (EPO) regulates
neural stem and progenitor cell function through interaction with
its receptor EPOR in the adult SVZ (Shingo et al., 2001; Tsai
et al., 2006; Chen et al., 2007; Wang et al., 2007). Administration
of recombinant human EPO (rhEPO) 24 h after stroke induced
sustained OPC proliferation in the peri-infarct white matter and
the SVZ (Zhang et al., 2010b). Moreover, rhEPO treatment sub-
stantially ampliﬁed myelinating oligodendrocytes and increased
myelinated axons in peri-infarct white matter (Jiang et al., 2006;
Zhang et al., 2010b). Thymosin β4 (Tβ4) is a G-actin binding
protein (Goldstein et al., 2005). Administration of Tβ4 24 h after
stroke robustly increased NG2 positive OPCs in the SVZ and
maturemyelinating oligodendrocytes andOPCs in the peri-infarct
striatum and corpus callosum 2months after stroke (Morris et al.,
2010). Treatment of stroke with cerebrolysin, a mixture of neu-
rotrophic peptides, ampliﬁed generation of OPCs in the SVZ
and mature oligodendrocytes in white matter of the peri-infarct
region (Zhang et al., 2010a, 2013). Furthermore, administration
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of mesenchymal stromal cells (MSCs) even at 7 days after stroke
substantially increased NG2 positive OPCs in the SVZ and MBP
positive oligodendrocytes in the peri-infarct striatum and cor-
pus callosum 4 months after stroke (Li et al., 2005). The effect
of MSCs on enhancement of oligodendrogenesis appears speciﬁc
because the treatment withMSCs signiﬁcantly reducedGFAP pos-
itive astrocytes in peri-infarct regions (Li et al., 2005). These data
indicate that cell and pharmacological based therapies amplify
stroke-induced oligodendrogenesis. Aging reduces oligodendro-
cytes in rodent and human brains (Sim et al., 2002; Pelvig et al.,
2008; Shen et al., 2008a,b). By tracking progeny of SVZ nestin lin-
eage neural progenitor cells in ischemic brain of transgenicmice at
age of 12months, a study shows that stroke increasednestin lineage
OPCs and oligodendrocytes and that administration of sildenaﬁl,
a potent phosphodiesterase type 5 (PDE5) inhibitor, further aug-
mented nestin lineage OPCs and oligodendrocytes in peri-infarct
corpus callosum and striatum (Zhang et al., 2012). These data
suggest that even in aged animals, oligodendrogenic potential is
present in SVZ neural progenitor cells in response to stroke and
the treatment. More importantly, increases in new oligodendro-
cytes are closely associated with augmentation of sprouting axons
in peri-infarct areas, which may contribute to functional recovery
after stroke, although further studies arewarranted to demonstrate
newly generated oligodendrocytes myelinate axons in peri-infarct
regions.
SIGNALING PATHWAYS MEDIATE OLIGODENDROGENESIS
IN THE ISCHEMIC BRAIN
Sonic hedgehog (Shh) is a member of the family of the hedge-
hog proteins and binds to the transmembrane receptor protein,
patched (ptc), which, in the absence of Shh, exerts an inhibitory
effect on the seven transmembrane receptor smoothened (Smo;
Ingham and McMahon, 2001; Gutierrez-Frias et al., 2004). In the
canonical way, binding of Shh to ptc blocks the inhibitory effect
of ptc on Smo. Once activated, Smo induces complex series of
intracellular reactions that targets the Gli family of transcription
factors (Ruiz i Altaba et al., 2002). In addition to neurogenesis, the
Shh signaling pathway regulates oligodendrogenesis by inducing
a basic helix-loop-helix transcription factor Olig2 that is required
for speciﬁcation of NG2 positive OPCs and mediates OPC dif-
ferentiation (Arnett et al., 2004; Ligon et al., 2004, 2006; de Castro
et al., 2013; Ferent et al., 2013). In the adult brain,Olig2-expressing
neural progenitor cells in the SVZ give rise to OPCs that migrate
to the white matter (Arnett et al., 2004; Ligon et al., 2006; Menn
et al., 2006). Stroke upregulated Shh signal in SVZ neural progen-
itor cells and blockage of the Shh pathway with cyclopamine, a
speciﬁc inhibitor of Smo, suppressed stroke-induced neural pro-
genitor cell proliferation and attenuated EPO-increased neural
progenitor cell proliferation (Wang et al., 2007; Liu et al., 2013a).
Furthermore, administration of cyclopamine to ischemic ani-
mals abolished cerebrolysin-enhanced oligodendrogenesis (Zhang
et al., 2013). Consistent with stroke, in amodel of focal demyelina-
tion induced by lysolecithin in the corpus callosum of adult mice,
the blocking of Shh signaling with its physiological antagonist,
hedgehog interacting protein, led to a decrease of OPC prolifera-
tion and differentiation (Ferent et al., 2013). Together, these data
suggest that the Shh pathway in SVZ neural progenitor cells plays
an important role inmediating oligodendrogenesis in the ischemic
brain.
Wnt signaling in adult neural progenitor cells regulates oligo-
dendrogenesis (Rafalski et al., 2013). Overexpression of Wnt3 in
SVZ neural progenitor cells results in a substantial and selective
increase of PDGFRα positive OPCs in adult mouse brain (Rafalski
et al., 2013). However, the canonic Wnt signaling pathway nega-
tively regulates OPC differentiation (Fancy et al., 2011). The rel-
evance of Wnt signaling to ischemia-induced oligodendrogenesis
remains to be established.
Phosphatidylinositol 3-kinase (PI3K) and its downstream
target, Akt, affect multiple cellular functions such as cell
survival,proliferation, and differentiation (Vojtek et al., 2003).
Mitogen-activated protein kinases (MAPKs) belong to fami-
lies of Ser/Thr-speciﬁc kinases activated by extracellular stim-
uli through protein phosphorylation (Rubinfeld and Seger,
2005). Extracellular signal-regulated kinases (ERKs), ERK1
and ERK2, are MAPKs (Rubinfeld and Seger, 2005). The
PI3K/Akt, p38MARK and ERK1/2 signals are involved in
OPC differentiation (Chew et al., 2010; Fyffe-Maricich et al.,
2011; Santra et al., 2012; Rafalski et al., 2013). Inhibition of
either p38 MAPK signaling with the inhibitor SB202190 or
PI3K with the inhibitor LY294002 signiﬁcantly reduces adult
neural progenitor cells generated OPCs (Santra et al., 2012;
Rafalski et al., 2013). Inactivation of p38MAPK with the inhibitor
SB202190 in adult neural progenitor cells activated ERK1/2 and
abolished Tβ4-increased OPCs (Santra et al., 2012). Therefore,
activation of PI3K/Akt and p38MAPK signals and cross-talk
between p38MAPK and ERK signals in neural progenitor cells
appear to be important in regulating generation of OPCs.
MICRORNAs MEDIATE PROCESSES OF
OLIGODENDROGENESIS AFTER STROKE
MicroRNAs (miRNAs), small non-coding RNAs, regulate neural
stem cell function and play a pivotal role in controlling processes
of OPC generation and differentiation (He et al., 2012). Dicer
is an endoribonuclease that cleaves double-stranded RNA and
pre-miRNA into short double-stranded RNA (Krol et al., 2010).
During development, disruption of miRNA biogenesis by condi-
tional ablation of Dicer in nestin lineage neural progenitor cells
results inneural progenitor cell death and abnormal neuronalOPC
differentiation (Kawase-Koga et al., 2009). Conditional deletion of
Dicer in Olig2 lineage cells led to impairment of OPC differenti-
ation (Dugas et al., 2010; Nave, 2010; Zhao et al., 2010), whereas
ablation of Dicer in proteolipid protein (PLP) lineage oligoden-
drocytes resulted in dysmyelination (Shin et al., 2009). These data
suggest that in addition to neural progenitor cells, miRNAs are
required for maintaining OPCs in the undifferentiated state and
for preserving myelin in mature oligodendrocytes. Indeed, studies
on miRNA proﬁles and functions show that OPCs and oligoden-
drocytes express distinct sets of miRNAs (Dugas et al., 2010; Nave,
2010; Zhao et al., 2010). For example, over expression of miR-219
and miR-338 in OPCs promoted oligodendrocyte differentiation
by repressing targeting genes including PDGFRa, Sox6, Zfp238,
FoxJ3, and Hes5 (Dugas et al., 2010; Zhao et al., 2010).
During development, the miR17-92 cluster, a cluster of seven
miRNAs, regulates processes of proliferation and survival of
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CNPase-expressing oligodendrocytes via upregulation of PTEN
and thus inactivation of Akt (Budde et al., 2010). The adult
SVZ neural progenitor cells expressed the miR17-92 cluster and
stroke substantially upregulated this cluster expression (Liu et al.,
2011, 2013a,b). Attenuation of members of the miR17-92 clus-
ter, miR18a and miR19a, or elevation of this cluster in adult SVZ
neural progenitor cells suppressed or enhanced neural progeni-
tor cell proliferation, respectively, via alteration of PTEN protein
levels (Liu et al., 2013a). Thus, the miR17-92 cluster may regulate
processes of oligodendrogenesis in adult brain. The Shh signaling
pathway functionally interacts with the miR-17-92 cluster in neu-
ral progenitor cells inmediating cell proliferation (Northcott et al.,
2009; Uziel et al., 2009). In vitro and in vivo studies show that acti-
vation and suppression of the Shh signaling pathway down- and
up- regulated, respectively, expression of the miR17-92 cluster
in SVZ neural progenitor cells under non-ischemic and ischemic
conditions (Liu et al., 2013a,b).
In addition, miR-9 and miR-200b are likely involved in stroke-
induced oligodendrogenesis by targeting serum response factor
(SRF; Buller et al., 2012). Stroke considerably downregulated
miR-9 and miR-200b in white matter. Overexpression of miR-9
and miR-200 in OPCs suppressed SRF expression and inhib-
ited OPC differentiation (Buller et al., 2012). Collectively, these
ﬁndings demonstrate that miRNAs are involved in processing
stroke-induced oligodendrogenesis.
HISTONE DEACETYLASES AND STROKE-INDUCED
OLIGODENDROGENESIS
Classes I and II histone deacetylase (HDAC) activity is required for
oligodendrocyte differentiation during brain development (Shen
and Casaccia-Bonneﬁl, 2008; Shen et al., 2008a,b). Pharmaco-
logical inhibition of HDAC activity and conditional ablation of
HDAC1 and HDAC2 in the oligodendrocyte lineage cells lead
to reduction of OPCs and mature oligodendrocytes (Shen and
Casaccia-Bonneﬁl, 2008; Shen et al., 2008a,b; Ye et al., 2009). There
are few studies that have examined the role of classes I and II
HDACs in mediating processes of oligodendrogenesis in ischemic
brain. Stroke increased HDAC 1 and HDAC2 proteins in OPC
nuclei and cytoplasmic HDAC4 proteins in OPCs, which was
accompanied by reduction of the acetylation levels of histones H3
and H4 (Kassis et al., 2013). Interestingly, treatment of stroke with
valproic acid, a panHDAC inhibitor, considerably increasedOPCs
and new oligodendrocytes in the adult rat (Liu et al., 2012). These
data suggest that HDACs are involved in stroke-induced oligo-
dendrogenesis. The sirtuins, a family of NAD-dependent histone
deacetylases, regulate crucial metabolic pathways and are linked to
lifespan (Penner et al., 2010; Yu andAuwerx, 2010). Inactivation of
SIRT1 in SVZ neural progenitor cells expanded OPCs, which was
mediated by activation of Akt and p38 MAPK signaling (Rafalski
et al., 2013). However, additional studies are needed to investigate
the speciﬁc roles of individual HDACs and SIRT1 in proliferation
and differentiation of OPCs during adult brain repair.
SUMMARY
Stroke induces oligodendrogenesis. OPCs resident in white matter
and OPCs derived from neural progenitor cells contribute to gen-
eration of mature myelination oligodendrocytes that interact with
axons and astrocytes during post stroke brain remodeling. Poten-
tial mechanisms underlying stroke-induced oligodendrogenesis
are emerging. Recent studies show that in addition to facilitat-
ing salutatory conduction, myelination in adult brain contribute
to maintaining axonal integrity, neural plasticity and circuitry
function (Fields, 2008; Nave, 2010; Fancy et al., 2011; Zatorre
et al., 2012; Young et al., 2013). It is essential for future studies
to investigate mechanisms that temporally and spatially coordi-
nate controlling oligodendrogenesis at multiple stages, and to
study relevance of remyelination by oligodendrogenesis to neu-
ronal circuitry, which will greatly enhance the development of
new therapies for stroke and other demyelination diseases.
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